RNA Sequencing Market Size, Share, Opportunities, And Trends By Technology (Ion Semiconductor Sequencing, Single-Molecule Real-Time (SMRT) Sequencing, Nanopore Sequencing, Sequencing By Synthesis (SBS)), By Applications (Small RNA Sequencing, Expression Profiling Analysis, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), By End-User (Research Centers, Biotechnology Labs, Healthcare Centers, Others), And By Geography - Forecasts From 2025 To 2030

RNA Sequencing Market Size:

The RNA sequencing market is projected to grow at a CAGR of 10.49% between 2025 and 2030

RNA sequencing is a known technique that is used to examine the sequences and quantity of RNA in a sample using next-generation sequencing (NGS). The major applications of RNA sequencing are investigating and discovering the transcriptome and the total cellular content of RNAs, including mRNA, rRNA, and tRNA. This allows scientists to understand the overall biology of a cell and assess changes that may indicate disease. Some of the most popular techniques that use RNA sequencing are transcriptional profiling, SNP identification, RNA editing, and differential gene expression analysis. RNA sequencing is considered more valuable as it is not limited to genomic sequences, has a low background signal, and is highly quantifiable.

What are the RNA Sequencing Market Drivers?

• Increasing adoption in various industries is anticipated to drive the RNA sequencing market

The global demand for RNA sequencing over traditional technologies is the major driving factor of industry growth. RNA sequencing has higher sensitivity for genes expressed either at low or very high levels and a higher dynamic range of expression levels over which transcripts can be detected (>8000-fold range). It also provides insight into the transcriptome of a cell compared to previous conventional technologies and recent advances in the RNA-Seq workflow, from sample preparation to library construction to data analysis. The effectiveness of RNA sequencing has led to many top industries adopting these technologies, leading to its growth. Its effectiveness in treating many diseases, such as cancer, has improved the healthcare system.

• Rising government support may positively impact the market.

With support from the government and private sectors, many developing countries have invested in their research and development sectors and in RNA sequencing programs to get a deep knowledge of genetics and diseases. Many such government organizations have actively participated in the sequencing program to find better ways of treating cancer and other diseases. Due to this large support, several new entrants have entered the market as many RNA sequencing projects have been introduced, leading to the overall growth of this industry and giving growth opportunities to key players.

• Less Cost of Sequencing and effectiveness in the treatment of cancer is predicted to boost the RNA sequencing market

Reducing the cost of genome sequencing has led to the widespread adoption of these techniques, thus positively impacting the adoption of RNA sequencing product lines. In addition to this, government organizations have offered significant funding for technological advancements, including RNA sequencing. RNA sequencing also facilitates the identification of differentially expressed genes, enabling several researchers to efficiently identify up-and down-regulated genes that are associated with different cancers

What are the RNA Sequencing Market Restraints?

• Lack of skill power and expenditure on Research and Development Programs may hamper the overall market

The expenditure on research and development in growing economies is mainly dependent on funding provided by external sources. Although governments and private bodies try to provide funds for research programs, many research firms and academic institutes are facing budget problems. They cannot afford advanced and premium-priced equipment and technologies. This further impacts the growth of these industries and their expansion in developing nations. RNA-based mappings depend on cDNA synthesis, posing a challenge in short-lived transcripts such as primary microRNAs, the efficiency of which depends on RNA sequence and structure. The lack of skilled professionals in this industry is less in number, which further hinders its growth. As a result, interpreting complex data takes time, and researchers face difficulties, leading to slow growth in the industry.

RNA Sequencing Market Geographical Outlook:

• North America is witnessing exponential growth during the forecast period.

The rapid evolution of structure-based drug design, increased focus on research in transcriptomics, and enormous investment in research and development of biopharmaceuticals are contributing factors in North America's expansion. The major stimulus behind the firms' top-line growth in the region is increased expenditure in research and drug development for pharmaceuticals.

RNA Sequencing Market Key Launches:

• In November 2024, Lexogen, a pioneer in NGS Services, introduced a streamlined Blood RNA-Seq Service to speed up drug discovery from whole blood or biofluids. Lexogen’s well-known blood transcriptomics solutions, such as CORALL for Blood and QuantSeq for Blood, provide effective globin removal and reliable workflows for thorough whole-transcriptome sequencing and economical gene expression profiling from blood.
• In May 2024, FoundationOne®RNA, a tissue-based RNA sequencing test for identifying cancer-related fusions across 318 genes, was introduced in the United States, according to Foundation Medicine, Inc.

RNA Sequencing Market Scope:

Report Metric	Details
Growth Rate	CAGR of 10.49%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Technology Applications End-User Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in the RNA Sequencing Market	Roche Holding AG Agilent Technologies Illumina, Inc. Thermo Fisher Scientific Macrogen, Inc.
Customization Scope	Free report customization with purchase

 

RNA Sequencing Market Segmentation:

• By Technology
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing
  • Nanopore Sequencing
  • Sequencing By Synthesis (SBS)
• By Applications
  • Small RNA Sequencing
  • Expression Profiling Analysis
  • De Novo Transcriptome Assembly
  • Variant Calling and Transcriptome Epigenetics
  • RNA Editing
• By End-User
  • Research Centers
  • Biotechnology Labs
  • Healthcare Centers
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • Spain
    • United Kingdom
    • Others
  • Middle East and Africa
    • UAE
    • Saudi Arabia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
    • Indonesia
    • Taiwan
    • Others

Our Best-Performing Industry Reports:

• RNA Analysis Market
• MicroRNA Market
• Next Generation Sequencers Market
• DNA Synthesizer Market
• DNA Digital Storage Market

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. RNA SEQUENCING MARKET BY TECHNOLOGY

5.1. Introduction

5.2. Ion Semiconductor Sequencing

5.3. Single-Molecule Real-Time (SMRT) Sequencing

5.4. Nanopore Sequencing

5.5. Sequencing By Synthesis (SBS)

6. RNA SEQUENCING MARKET BY APPLICATION

6.1. Introduction

6.2. Small RNA Sequencing

6.3. Expression Profiling Analysis

6.4. De Novo Transcriptome Assembly

6.5. Variant Calling and Transcriptome Epigenetics

6.6. RNA Editing

7. RNA SEQUENCING MARKET BY END-USER 

7.1. Introduction

7.2. Research Centers

7.3. Biotechnology Labs

7.4. Healthcare Centers

7.5. Others

8. RNA SEQUENCING MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Technology

8.2.2. By Application

8.2.3. By End-User 

8.2.4. By Country

8.2.4.1. United States

8.2.4.2. Canada

8.2.4.3. Mexico

8.3. South America

8.3.1. By Technology

8.3.2. By Application

8.3.3. By End-User 

8.3.4. By Country

8.3.4.1. Brazil

8.3.4.2. Argentina

8.3.4.3. Others

8.4. Europe

8.4.1. By Technology

8.4.2. By Application

8.4.3. By End-User 

8.4.4. By Country

8.4.4.1. Germany

8.4.4.2. France

8.4.4.3. Spain

8.4.4.4. United Kingdom

8.4.4.5. Others

8.5. Middle East and Africa

8.5.1. By Technology

8.5.2. By Application

8.5.3. By End-User 

8.5.4. By Country

8.5.4.1. UAE

8.5.4.2. Saudi Arabia

8.5.4.3. Others

8.5.5. By Technology

8.5.6. By Application

8.5.7. By End-User 

8.5.8. By Country

8.5.8.1. China

8.5.8.2. Japan

8.5.8.3. India

8.5.8.4. South Korea

8.5.8.5. Thailand

8.5.8.6. Indonesia

8.5.8.7. Taiwan

8.5.8.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Roche Holding AG

10.2. Agilent Technologies

10.3. Illumina, Inc.

10.4. Thermo Fisher Scientific

10.5. Macrogen, Inc.

10.6. Beijing Genomics Institute

10.7. Qiagen

10.8. DNASTAR

10.9. GATC Biotech AG

10.10. Pacific Biosciences of California, Inc.

Roche Holding AG

Agilent Technologies

Illumina, Inc.

Thermo Fisher Scientific

Macrogen, Inc.

Beijing Genomics Institute

Qiagen

DNASTAR

GATC Biotech AG

Pacific Biosciences of California, Inc.